Strand Life Sciences Opens Genomics Center In San Francisco
Tech & Pharma
December 13, 2013
Strand Life Sciences is collaborating with El Camino Hospital to open a Strand Center for Genomics and Personalized Medicine in San Francisco, US.
AsianScientist (Dec. 13, 2013) – Strand Life Sciences Private Limited in Bangalore is collaborating with El Camino Hospital to open a Strand Center for Genomics and Personalized Medicine in San Francisco.
This signals the start of a collaborative effort to bring advanced genomic tests in cardiology, oncology, pharmaco-genomics and personalized medicine to the community served by the El Camino Hospital.
“El Camino is very excited to work with Strand Life Sciences on a series of projects around bringing genomic medicine to clinical practice. ECH is focused on the practical aspects of clinical medicine, while Strand’s expertise, as embodied by their tagline, lies in providing ‘Algorithms for Life.’ So it is a perfect marriage between partners with diverse expertise and a unified vision,” said Dr. Eric Pifer, chief medical officer of El Camino Hospital.
The El Camino Hospital has an active Genomic Medicine Institute that has been engaged in continuing education in genomics for physicians and some genetic counseling of patients. The hospital is also well known for its South Asian Heart Study that has addressed the disproportionate risk of cardiac disease seen in the South Asian population located in the Bay Area.
Strand has been a pioneer in the delivery of advanced clinical genomics solutions for healthcare institutions in India since early 2013. Coming from this new focus is StrandOmics™, a proprietary solution for clinical interpretation of genomic variants in patient samples with deeper insights leading to informed decisions by physicians.
Source: Strand Life Sciences.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.